BGI and EEG Market Size, Share & Trends Analysis Report By Product (Hardware, Software, Service), By Applications (medical and consumer), By End Use, By Region, and Segment Forecasts - 2035

BGI and EEG Market Overview

The bgi and eeg market size is expected to grow from USD 961.53 million in 2025 to USD 1114.22 million in 2026 and is forecast to reach USD 1733.8 million by 2035 at 15.88% CAGR over 2026-2035.

The BGI and EEG market is moving into a higher-growth phase as advances in brain-computer interfaces, electroencephalography, artificial intelligence, wearable sensing, signal processing, and neurorehabilitation broaden the practical use of brain activity data. In 2026, demand is no longer limited to conventional neurological monitoring because research laboratories, hospitals, rehabilitation centers, technology developers, and consumer applications are increasingly exploring non-invasive brain signal acquisition. Hardware remains central to market development, but software and service capabilities are becoming more important as organizations seek complete systems for acquisition, processing, interpretation, visualization, and application deployment. The market is supported by 3 major technology directions: higher-quality signal capture, more sophisticated computational analysis, and increasingly portable interfaces. Current commercial EEG platforms can range from 1-channel consumer configurations to systems exceeding 100 channels for advanced research, while high-density research systems can reach 256 channels. These developments are expanding the addressable market for BGI and EEG solutions across medical and consumer environments. The forecast increase to USD 1733.8 million by 2035 also reflects growing interest in brain-controlled interfaces, cognitive monitoring, neurorehabilitation, accessibility technologies, research automation, and personalized neurological assessment. Manufacturers are therefore shifting from standalone instrumentation toward integrated ecosystems combining hardware, software, cloud connectivity, analytics, artificial intelligence, and professional services.

USA BGI and EEG demand remains strategically important because the country combines advanced neurological care, extensive research infrastructure, strong medical-device development, technology investment, and a rapidly expanding ecosystem of brain-computer interface applications. During 2026, medical applications continue to represent the more established demand base, particularly for EEG monitoring, epilepsy assessment, neurological research, rehabilitation, and brain-controlled assistive technologies. Consumer applications are simultaneously gaining attention through wearable EEG, cognitive performance monitoring, gaming, human-computer interaction, and neuroadaptive experiences. The United States is also an important center for software development and AI-enabled EEG interpretation, with companies increasingly integrating machine-learning models into signal processing and application platforms. Regulatory progress is becoming another market catalyst; during 2025, a new EEG system from Nihon Kohden received U.S. regulatory clearance, demonstrating continued product development in clinical neurodiagnostic equipment. With the overall BGI and EEG market projected to expand at 15.88% CAGR through 2035, U.S. companies, research institutions, and healthcare organizations are expected to remain influential in both medical commercialization and consumer neurotechnology development.

• 

  Download Free sample to learn more about this report.

Key Findings

• Leading Product Type: Hardware is expected to remain the leading category, supported by approximately 52% market share in 2026 as EEG headsets, amplifiers, sensors, and acquisition systems provide the foundation for BGI applications.
• Leading Application: Medical applications are projected to dominate with an estimated 71% share in 2026, reflecting established demand for neurological monitoring, research, rehabilitation, and clinically oriented brain-signal analysis.
• Leading Region: North America is expected to lead with approximately 39% market share in 2026, supported by advanced neurotechnology research, strong clinical infrastructure, and significant investment in brain-computer interface development.
• Fastest Growing Region: Asia-Pacific is projected to record the fastest expansion, with growth approaching 19% annually in stronger markets as neurological care, AI research, wearable devices, and digital health infrastructure accelerate.
• Technology Trend: High-density EEG is advancing rapidly, with research systems using 256 channels demonstrating substantially higher information-transfer potential than conventional lower-channel configurations for advanced brain-computer interfaces.
• Market Driver: Artificial intelligence is becoming a major growth catalyst, with recent EEG classification research demonstrating accuracy above 97% for selected emotion categories using machine-learning signal analysis.
• Competitive Landscape: Suppliers are increasingly combining EEG hardware, software, analytics, and developer tools; leading wearable platforms now span configurations from 2 channels to 32 channels for different research and consumer requirements.
• Future Outlook: The market is projected to reach USD 1733.8 million by 2035, supported by a 15.88% CAGR and expanding use of brain-signal technologies across medical and consumer environments.

Latest Trends

The latest BGI and EEG market trends are centered on portability, artificial intelligence, multimodal interpretation, wireless connectivity, and the transition of EEG technology from laboratory environments toward real-world use. During 2026, wearable EEG systems are becoming increasingly compact, with commercial platforms available in configurations such as 2-channel ear-worn devices, 5-channel headbands, 14-channel headsets, and 32-channel flexible systems. This broader hardware range enables suppliers to address different price points and application requirements without relying on a single device architecture. The growing use of cloud-connected platforms is also changing the economics of EEG deployment because researchers and developers can increasingly process, visualize, and manage neural data through software ecosystems rather than depending entirely on local computing infrastructure. Artificial intelligence is becoming particularly important for artifact removal, feature extraction, classification, cognitive-state interpretation, and adaptive interfaces. As machine-learning models become more capable of handling complex EEG signals, software is shifting from a supporting role toward becoming a major source of product differentiation.

Another important trend is the convergence of EEG with brain-computer interfaces and consumer technology. Consumer-facing applications are increasingly exploring focus monitoring, gaming, cognitive performance, neuroadaptive interfaces, and accessibility, while medical applications continue to emphasize epilepsy, neurological assessment, rehabilitation, and assistive communication. In 2025 and 2026, companies have increasingly emphasized integrated platforms that connect sensing, signal interpretation, APIs, and application development. Research is also moving toward foundation models capable of processing EEG data across devices and environments, although generalization remains challenging because EEG signals vary substantially between individuals and recording conditions. High-density systems are also attracting attention because 256-channel research configurations can capture substantially richer spatial information than low-channel devices. Together, these trends are increasing demand for hardware, software, and service models capable of supporting both controlled clinical studies and everyday brain-signal applications.

Market Dynamics

Driver

"AI-enabled brain-signal interpretation is accelerating practical EEG adoption."

The strongest driver for the BGI and EEG market is the rapid improvement of artificial intelligence and machine-learning techniques for interpreting brain signals. Traditional EEG systems can generate large volumes of complex time-series information, making manual analysis resource-intensive when datasets contain hundreds of channels or long recording sessions. AI can automate signal classification, artifact detection, feature extraction, pattern recognition, and prediction, increasing the practical value of EEG data. In 2025, research using EEG signals and machine-learning classification reported accuracy above 97% for one selected emotion category, demonstrating the potential for computational interpretation when appropriate datasets and models are used. The combination of AI and EEG is expanding opportunities across medical and consumer applications. Hospitals can use advanced analytics to support neurological assessment, while consumer developers can explore cognitive-state interfaces and adaptive applications. As the market grows at 15.88% CAGR through 2035, AI-enabled software is likely to become one of the most important mechanisms for converting raw EEG measurements into actionable information.

Another element supporting this driver is the growing availability of affordable and portable hardware. Earlier EEG deployments often required dedicated laboratories, specialized technicians, and complex electrode preparation. Modern systems increasingly provide wireless acquisition, wearable form factors, simplified electrode placement, and software-based signal processing. Commercial devices now span configurations from approximately 2 channels to 32 channels, while specialized research systems can reach 256 channels. This creates a tiered market in which medical organizations can acquire high-performance systems while consumer and research developers can select more compact devices. The resulting reduction in hardware complexity expands experimentation and increases the number of developers able to build BGI applications. As more datasets become available, AI models can also benefit from larger training populations and broader experimental conditions.

Restraint

"Signal variability and system complexity continue to limit universal EEG deployment."

EEG signals are highly sensitive to electrode placement, movement, environmental interference, muscle activity, individual physiology, and recording conditions, creating a significant restraint for commercial and medical deployment. A model trained on data from one population may not produce the same performance when applied to another population, another device, or a different recording environment. This problem becomes more important when systems move from controlled laboratories to everyday consumer settings. Even when a headset has 14, 32, or 64 channels, the quality of the resulting information depends on electrode contact, impedance, placement consistency, sampling configuration, and signal-processing methods. Consequently, manufacturers must invest heavily in hardware validation, software calibration, and user training. These requirements can increase deployment time and raise the total cost of implementation.

Another restraint is the difference between research-grade EEG and consumer-grade EEG. Medical environments generally require rigorous performance validation, regulatory compliance, documentation, cybersecurity controls, and clinical workflows, whereas consumer systems often prioritize comfort, portability, simplicity, and affordability. Bridging these requirements is difficult because a device optimized for a 5-minute consumer interaction may not satisfy the needs of a multi-hour clinical recording. The market therefore remains segmented across different performance levels. This complexity can slow procurement decisions and make it harder for smaller companies to compete with established manufacturers that have decades of experience in neurological instrumentation.

Opportunity

"Wearable neurotechnology is opening new medical and consumer opportunities."

Wearable neurotechnology represents one of the strongest opportunities because it expands EEG beyond traditional hospital and laboratory environments. Lightweight headsets, flexible sensor arrangements, and ear-worn EEG devices can support brain monitoring while users perform everyday activities. Commercial platforms already include 2-channel ear-worn configurations, 5-channel headbands, 14-channel systems, and 32-channel flexible research devices. This range enables companies to create products for different levels of signal complexity. Consumer applications can target gaming, concentration, cognitive training, and human-computer interaction, while medical and research users can apply wearable systems to monitoring, rehabilitation studies, and longitudinal assessments.

Asia-Pacific provides another substantial opportunity because several countries are simultaneously investing in healthcare digitization, artificial intelligence, neuroscience research, and advanced electronics. Regional market growth approaching 19% annually in stronger markets could outpace mature economies and create opportunities for companies that establish localized manufacturing, distribution, training, and technical support. The development of affordable EEG platforms could also support neurological assessment in areas where access to sophisticated hospital equipment remains limited. Research using low-cost single-channel EEG has already demonstrated potential for meaningful data analysis in resource-constrained settings. As hardware becomes more accessible, software companies can build additional value through analytics, remote monitoring, and AI-enabled interpretation.

Challenge

"Privacy, interoperability, and clinical validation remain major commercialization challenges."

The BGI and EEG market faces a complex challenge in protecting neural data while simultaneously creating useful digital applications. Brain signals can contain sensitive information about cognitive states, attention, responses, and potentially other neurological characteristics. As consumer applications expand, organizations must establish clear controls around data collection, storage, processing, sharing, and user consent. A platform that connects wearable EEG hardware with cloud analytics and third-party applications may involve several data-processing layers, creating additional cybersecurity requirements. Companies must therefore balance innovation with privacy protection, transparent data policies, and appropriate governance. These considerations become increasingly important as neurotechnology moves into everyday consumer environments.

Interoperability is another challenge because EEG hardware, recording formats, software environments, APIs, electrode configurations, and analysis pipelines can vary substantially between suppliers. A research group using one 32-channel system may require different preprocessing steps from another group using a 64-channel or 256-channel platform. Lack of standardization can increase development time and reduce the portability of machine-learning models. Clinical validation creates another hurdle because algorithms must demonstrate reliable performance across diverse populations and recording conditions. As the market expands toward USD 1733.8 million by 2035, companies that solve interoperability and validation problems will be better positioned to convert technological potential into scalable commercial applications.

• 

  Download Free sample to learn more about this report.

Segmentation Analysis

By Types

Hardware: Hardware is estimated to represent approximately 52% of the BGI and EEG market in 2026, making it the largest supplied product category. EEG amplifiers, electrodes, sensors, headsets, acquisition systems, and related equipment form the physical foundation for brain-signal measurement. Medical demand remains particularly important because hospitals and research organizations require dependable signal quality, channel stability, and repeatable acquisition. Consumer demand is simultaneously increasing interest in wireless, lightweight, and wearable designs. Hardware suppliers are therefore balancing clinical-grade performance with greater portability. Systems ranging from 2-channel wearable devices to 32-channel research headsets illustrate the increasing diversity of the category. Through 2035, hardware is expected to remain central because every BGI and EEG application requires a reliable mechanism for capturing neural activity.

Software: Software is projected to account for approximately 31% of the market in 2026 and is expected to record strong growth as AI, signal processing, cloud platforms, and application programming interfaces become more important. EEG software can manage acquisition, visualization, filtering, artifact removal, event marking, analysis, classification, and reporting. Modern platforms are increasingly designed as integrated environments rather than isolated analysis tools. Recent software developments include improved EEG recording workflows, advanced analysis releases, cloud-connected developer environments, and AI-assisted interpretation. Software also provides a pathway for recurring value creation because users may require updates, analytics, storage, models, and development services after purchasing hardware. As the market expands at 15.88% CAGR, software is expected to gain share as organizations seek complete brain-data ecosystems.

Service: Service is estimated to represent approximately 17% of the BGI and EEG market in 2026 and includes technical support, installation, training, maintenance, consulting, research support, and system integration activities. Service demand is increasing because advanced EEG environments can involve complex electrode configurations, software workflows, data management, and specialized interpretation. Medical organizations may require implementation assistance, while research institutions often need training and technical support for multi-channel experiments. Consumer technology developers can also require API integration, model development, and application support. Service providers that combine neuroscience expertise with software and engineering capabilities can therefore capture opportunities beyond hardware sales. The category is expected to expand steadily through 2035 as the installed base of BGI and EEG systems increases.

By Applications

medical: Medical applications are estimated to represent approximately 71% of total market demand in 2026 and remain the largest application category. Clinical EEG is widely associated with neurological monitoring, epilepsy assessment, sleep-related evaluation, brain activity studies, rehabilitation, and other medical applications. The category benefits from established clinical workflows, professional expertise, and continuing investment in neurological diagnostics. Advanced BGI technologies are also expanding opportunities for assistive communication and rehabilitation. Medical customers typically prioritize signal quality, reliability, validation, data security, and regulatory compliance. As neurological disease burden and demand for non-invasive monitoring increase, medical applications are expected to remain the primary foundation of market growth through 2035.

consumer: Consumer applications are projected to account for approximately 29% of the market in 2026 and are expected to grow faster than many traditional applications as wearable neurotechnology becomes more accessible. Consumer products are being developed for gaming, cognitive performance, concentration monitoring, human-computer interaction, wellness-oriented experiences, and neuroadaptive interfaces. The category favors compact form factors, simple electrode placement, wireless connectivity, and software platforms that translate EEG data into understandable outputs. Devices using 2 to 14 channels can support many lightweight applications without the complexity of high-density systems. As consumer awareness increases, companies are expected to expand from standalone EEG headsets toward integrated experiences involving software, artificial intelligence, mobile applications, and cloud-based analytics.

• 

  Download Free sampleto learn more about this report.

Regional Outlook

North America

North America is expected to remain the leading regional market, accounting for approximately 39% of global BGI and EEG demand in 2026. The region benefits from advanced neurological healthcare infrastructure, strong university research networks, established medical-device manufacturers, and significant investment in brain-computer interfaces. The United States represents the primary regional demand center, with medical applications accounting for the majority of current deployments. Hospitals, neurological centers, rehabilitation organizations, technology companies, and research institutions collectively create demand for hardware, software, and service solutions.

North America also provides a favorable environment for consumer neurotechnology because technology developers and research organizations increasingly experiment with wearable EEG, gaming interfaces, cognitive applications, and AI-enabled brain-data platforms. Regulatory development remains important, with clinical EEG product clearances continuing during 2025 and 2026. The region's competitive environment includes companies specializing in hardware, implanted and non-invasive BGI technologies, software, and analytics. Through 2035, North America is expected to maintain leadership because of strong research investment, high healthcare technology adoption, and established commercial ecosystems.

Europe

Europe is estimated to represent approximately 27% of the global market in 2026 and remains one of the most important regions for EEG research, clinical neurotechnology, and brain-computer interface development. Germany, the Netherlands, Italy, Austria, Spain, Switzerland, and other European markets contain established companies and research centers working across EEG hardware, signal processing, neurorehabilitation, and BGI applications. European institutions also contribute substantially to academic neuroscience and medical technology research, supporting demand for high-quality acquisition systems and advanced analytical software.

European market development is increasingly influenced by data governance, cybersecurity, medical-device regulation, and responsible use of neural information. These requirements can increase development complexity but also encourage higher product quality and transparency. The region is well positioned for growth in medical applications because neurological monitoring and research are already established, while consumer applications can expand through wearable EEG and human-computer interaction. With approximately 15.88% global market CAGR through 2035, European companies are expected to remain important contributors to software, hardware, and specialized service innovation.

Asia-Pacific

Asia-Pacific is projected to account for approximately 22% of the BGI and EEG market in 2026 and is expected to record the fastest regional expansion. Growth is supported by increasing neurological healthcare capacity, large patient populations, expanding research infrastructure, artificial intelligence investment, electronics manufacturing capabilities, and rising interest in wearable technologies. China, Japan, South Korea, India, and Australia are expected to remain important contributors, although the development profile differs substantially between individual countries. Medical applications provide the current foundation, while consumer neurotechnology is gaining visibility.

Regional growth approaching 19% annually in stronger markets creates substantial opportunities for suppliers of affordable EEG hardware, AI software, and technical services. Low-cost devices can support research and neurological assessment in settings where advanced hospital systems are less accessible. At the same time, technologically advanced economies can support high-density research, BGI development, and consumer neurotechnology. Companies entering the region will need localized distribution, regulatory expertise, technical training, and pricing strategies adapted to different healthcare environments. Through 2035, Asia-Pacific is expected to narrow the gap with mature markets as neurotechnology adoption broadens.

Middle East & Africa

Middle East & Africa is estimated to represent approximately 12% of the global BGI and EEG market in 2026, with demand concentrated in major healthcare centers and research institutions. Gulf countries are investing in advanced healthcare technologies and specialized neurological services, creating opportunities for high-performance EEG systems and integrated software. African markets present a different opportunity profile, with demand increasingly influenced by affordability, portability, technical simplicity, and availability of trained personnel. Medical applications currently represent the dominant source of regional demand.

Portable EEG systems can provide particular value in markets where large neurological facilities are concentrated in major urban centers. Devices using fewer channels can reduce equipment complexity and support mobile or decentralized research environments. Service capabilities are also important because installation, training, maintenance, and technical support can influence the long-term utilization of sophisticated systems. Through 2035, regional growth is expected to be supported by healthcare modernization, expanding neurological services, and increasing interest in AI-enabled diagnostic and monitoring technologies.

USA Market Analysis

The United States is expected to account for approximately 35% of North American BGI and EEG demand in 2026 and remains one of the world's most influential markets for neurotechnology. Demand is supported by hospitals, neurological centers, universities, technology companies, rehabilitation organizations, and specialized research laboratories. Medical applications continue to dominate because EEG is an established neurological measurement technology, while consumer applications are expanding through wearable devices, gaming, cognitive monitoring, and human-computer interaction.

The U.S. competitive environment is also characterized by strong integration between hardware and software. Companies are increasingly developing platforms that capture EEG data, process signals, apply AI models, and provide application interfaces through a connected ecosystem. During 2025, a new EEG system received U.S. regulatory clearance, demonstrating continued investment in clinical neurodiagnostic technologies. Through 2035, the United States is expected to remain a major center for product development, regulatory advancement, clinical research, and commercialization of BGI and EEG systems.

List of Top BGI and EEG Companies

• SYMTOP
• Brain Products GmbH
• NeuroSky Inc
• Compumedics Limited
• Emotiv Inc
• EGI
• NeuroPace Inc
• Micromed
• G.TEC
• Artinis Medical Systems BV
• Mindmaze SA
• Medtronic
• Cadwell
• Blackrock Microsystems LLC
• Nihon Kohden
• NCC Medical
• InteraXon
• ANT Neuro B.V
• Neuroelectrics
• BrainCo

Top 2 Companies Market Share

Brain Products GmbH: Brain Products is estimated to hold approximately 9% of the global BGI and EEG market in 2026, supported by its strong research-oriented EEG portfolio, recording systems, analysis software, training ecosystem, and international neuroscience customer base. Its competitive position is reinforced by continued software development, including updated BrainVision analysis and recording capabilities during 2025 and 2026.

Emotiv Inc: Emotiv is estimated to account for approximately 7% of global market demand in 2026, with competitive strength derived from wireless EEG hardware, developer tools, software, APIs, and consumer-oriented neurotechnology. Its product portfolio spans configurations including 2-channel, 5-channel, 14-channel, and 32-channel systems, allowing the company to address multiple research and application requirements.

Investment Analysis

Investment opportunities in the BGI and EEG market are increasingly shifting toward integrated platforms rather than standalone hardware. Hardware is expected to hold approximately 52% of the market in 2026, but software and service categories are expanding as customers demand complete workflows for acquisition, processing, interpretation, and application development. Investors are therefore likely to prioritize companies that combine EEG hardware with proprietary analytics, AI models, cloud infrastructure, APIs, or recurring technical services. High-density systems, wearable devices, and flexible acquisition platforms offer additional opportunities because they serve different levels of research and clinical complexity. Companies capable of producing 2-channel consumer devices alongside 32-channel or higher research systems can address multiple customer segments and reduce reliance on one application category.

Geographic investment is another important opportunity, particularly in Asia-Pacific, where annual growth approaching 19% in stronger markets could significantly exceed mature-market expansion. Investment in local distribution, regulatory expertise, technical training, and affordable hardware could accelerate adoption in emerging healthcare systems. North America remains attractive because approximately 39% of global demand is expected to originate from the region in 2026, providing a strong base for premium clinical and research technologies. Europe offers opportunities in advanced EEG research, while Middle East & Africa can benefit from portable systems and service-led deployment models. Investors should therefore evaluate product scalability, software differentiation, regulatory readiness, data security, and regional service capabilities alongside conventional hardware performance.

New Product Development

New product development is increasingly focused on making EEG systems easier to deploy without compromising signal quality. In 2025 and 2026, manufacturers have emphasized improved recording workflows, simplified electrode attachment, wireless connectivity, flexible channel configurations, and more intuitive analysis environments. Research-grade platforms are simultaneously increasing channel density, with systems reaching 256 channels for advanced neuroscience applications. At the opposite end, compact devices using 2 or 5 channels are becoming more practical for consumer and portable applications. This creates a broad development spectrum in which product designers can optimize systems for clinical precision, research flexibility, or consumer convenience.

Software development is becoming equally important. Recent releases have focused on improving EEG recording, analysis performance, usability, and workflow integration. AI-enabled systems are also moving toward automated artifact handling, cognitive-state interpretation, and device-agnostic signal analysis. Developers are increasingly building platforms that connect neural sensing, interpretation, and application deployment within a single environment. Over the 2026-2035 period, new products are expected to emphasize lower setup time, better signal robustness, smaller form factors, stronger cybersecurity, cloud compatibility, and more transparent AI outputs. Companies that successfully integrate these capabilities can create differentiated solutions across both medical and consumer applications.

Five Recent Developments

• March 2024: EEG manufacturers continued expanding portable and wireless configurations, strengthening the transition from laboratory-only systems toward flexible research and consumer environments using compact multi-channel headsets.
• November 2024: Brain-computer interface developers increased focus on AI-assisted EEG interpretation, with research programs emphasizing automated classification, signal preprocessing, and more robust brain-signal decoding across diverse datasets.
• May 2025: Nihon Kohden advanced its clinical EEG portfolio through regulatory activity involving its Neurofax EEG system, supporting continued development of professional neurological monitoring technologies.
• December 2025: Brain Products announced an upgraded BrainVision recording environment designed to improve EEG recording workflows, usability, flexibility, and compatibility with established actiCHamp systems.
• July 2026: Brain Products released BrainVision Analyzer 2.3.2 and related analysis solutions, reflecting continued software investment in EEG processing, performance, usability, and research workflow optimization.

Report Coverage

This BGI and EEG Market Report covers market development across 2026-2035 and evaluates the three supplied product categories of Hardware, Software, and Service. Application analysis covers medical and consumer uses, while regional analysis examines North America, Europe, Asia-Pacific, and Middle East & Africa, with additional focus on the United States. The assessment addresses market drivers, restraints, opportunities, challenges, latest trends, product development, investment conditions, competitive strategies, and regional demand patterns. The market is forecast to expand from USD 1114.22 million in 2026 to USD 1733.8 million by 2035 at a 15.88% CAGR.

The competitive assessment includes SYMTOP, Brain Products GmbH, NeuroSky Inc, Compumedics Limited, Emotiv Inc, EGI, NeuroPace Inc, Micromed, G.TEC, Artinis Medical Systems BV, Mindmaze SA, Medtronic, Cadwell, Blackrock Microsystems LLC, Nihon Kohden, NCC Medical, InteraXon, ANT Neuro B.V, Neuroelectrics, BrainCo, Natus Medical, and Advanced Brain Monitoring. The report is designed for manufacturers, healthcare organizations, research institutions, technology developers, investors, procurement teams, and strategic decision-makers evaluating opportunities in brain-computer interfaces, EEG systems, neurotechnology, and brain-data applications.